Gujarat India based Zydus Cadila's Covid-19 vaccine ZyCoV-D, meant for adults and children aged 12 years and above, was today approved for "restricted use in emergency situation" by the Central Drugs Standard Control Organization (CDSCO) which is India's regulator. The DNA vaccine, developed in partnership with India's Department of Biotechnology,...
Another Covid-19 Vaccine Enters Production in India
India's Cadila Healthcare has started producing its potential COVID-19 vaccine for which it will seek emergency use authorization in May or June, its managing director was quoted as saying, with an aim to make up to 240 million doses a year. Its DNA plasmid product - which involves the injection...